Different patterns of toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins

Infection and Immunity

Volumn 80, Issue 5, 2012, Pages 1917-1922

  Ioana, M ^a,b,c   Ferwerd, B ^a,d   Plantinga, T S ^a   Stappers, M ^a   Oosting, M ^a   McCall, M ^a   Cimpoeru, A ^b   Burada, F ^b   Panduru, N ^c   Sauerwein, R ^a   Doumbo, O ^e   van der Meer, J W M ^a   van Crevel, R ^a   Joosten, L A B ^a   Netea, M G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF BAMAKO   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHINESE; CONTROLLED STUDY; ETHNICITY; EUROPE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HOST RESISTANCE; HUMAN; INDIAN; INFECTION SENSITIVITY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; POPULATION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PSEUDOGENE; SOUTH ASIA; STAPHYLOCOCCUS AUREUS;

ALLELES; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-6; LIGANDS; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 2;

EID: 84861127524     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00121-12     Document Type: Article

References (63)

1. Ajdary S, Ghamilouie MM, Alimohammadian MH, Hosseini M, Pakzad SR. 2010. Lack of association of Toll-like receptor 2 Arg753Gln with cutaneous leishmaniasis. Parasitol. Int. 59:466-468.
2. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. 4:499-511.
3. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
4. Aliprantis AO, et al. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736-739.
5. Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. 2004. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 11:625-626.
6. Berdeli A, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. 2005. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J. Mol. Med. (Berlin) 83:535-541.
7. Biswas D, Gupta SK, Sindhwani G, Patras A. 2009. TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients. BMC Res. Notes 2:162.
8. Bochud PY, et al. 2008. Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. J. Infect. Dis. 197:253-261.
9. Casals M, Pila P, Langohr K, Millet JP, Cayla JA. Incidence of infectious diseases and survival among the Roma population: a longitudinal cohort study. Eur. J. Public Health, in press.
10. Caws M, et al. 2008. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 4:e1000034.
11. Chaix R, Austerlitz F, Morar B, Kalaydjieva L, Heyer E. 2004. Vlax Roma history: what do coalescent-based methods tell us? Eur. J. Hum. Genet. 12:285-292.
12. Cheng PL, Eng HL, Chou MH, You HL, Lin TM. 2007. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl. Res. 150:311-318.
13. Cosan F, et al. 2009. No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behcet's disease. Clin. Rheumatol. 28:1385-1388.
14. Duzgun N, Duman T, Haydardedeoglu FE, Tutkak H. 2007. The lack of genetic association of the Toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease. Clin. Rheumatol. 26:915-919.
15. Endres S, Ghorbani R, Lonnemann G, van der Meer JW, Dinarello CA. 1988. Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin. Immunol. Immunopathol. 49:424-438.
16. Etokebe GE, et al. 2010. Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele. Scand. J. Immunol. 71:369-381.
17. Ferwerda B, et al. 2009. Functional and genetic evidence that the Mal/ TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc. Natl. Acad. Sci. U. S. A. 106:10272-10277.
18. Ferwerda B, et al. 2007. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. U. S. A. 104:16645-16650.
19. Fraser A. 1992. The gypsies. Blackwell Publishers, Oxford, United Kingdom.
20. Georgel P, Macquin C, Bahram S. 2009. The heterogeneous allelic repertoire of human Toll-like receptor (TLR) genes. PLoS One 4:e7803.
21. Gerold G, Zychlinsky A, de Diego JL. 2007. What is the role of Toll-like receptors in bacterial infections? Semin. Immunol. 19:41-47.
22. Hashimoto C, Hudson KL, Anderson KV. 1988. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52:269-279.
23. Hong J, et al. 2007. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J. Gastroenterol. Hepatol. 22:1760-1766.
24. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
25. Kang TJ, Chae GT. 2001. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol. 31:53-58.
26. Kivisild T, et al. 1999. Deep common ancestry of Indian and western-Eurasian mitochondrial DNA lineages. Curr. Biol. 9:1331-1334.
27. Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R. 2011. Innate immune recognition of Mycobacterium tuberculosis. Clin. Dev. Immunol. 2011:405310.
28. Kumar H, Kawai T, Akira S. 2009. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388:621-625.
29. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-983.
30. Lewis MP. 2009. Ethnologue: languages of the world, 16th ed. SIL International, Dallas, TX.
31. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. 2000. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68:6398-6401.
32. Ma MJ, et al. 2010. Toll-like receptors, tumor necrosis factor-alpha, and interleukin-10 gene polymorphisms in risk of pulmonary tuberculosis and disease severity. Hum. Immunol. 71:1005-1010.
33. Malhotra D, Relhan V, Reddy BS, Bamezai R. 2005. TLR2 Arg677Trp polymorphism in leprosy: revisited. Hum. Genet. 116:413-415.
34. Mikita N, et al. 2009. No involvement of non-synonymous TLR2 polymorphisms in Japanese leprosy patients. J. Dermatol. Sci. 54:48-49.
35. Moens L, et al. 2007. Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease. Microbes Infect. 9:15-20.
36. Ogus AC, et al. 2004. The Arg753GLn polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J. 23:219-223.
37. Ozen S, et al. 2006. Arg753Gln TLR-2 polymorphism in familial Mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. J. Rheumatol. 33:2498-2500.
38. Ozinsky A, et al. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. U. S. A. 97:13766-13771.
39. Pabst S, et al. 2009. Toll-like receptor 2 gene polymorphisms Arg677Trp and Arg753Gln in chronic obstructive pulmonary disease. Lung 187:173-178.
40. Parwati I, van Crevel R, van Soolingen D. 2010. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 10:103-111.
41. Quintana-Murci L, et al. 1999. Genetic evidence of an early exit of Homo sapiens sapiens from Africa through eastern Africa. Nat. Genet. 23:437-441.
42. Rochow I, Matschke K. 1998. Neues zu den zigeunern im Byzantinischen reich um die wende von 13. Zum 14. Jahrhundert. Jahrbuch der O sterreichischen Byzantinistik, p 241-254. VÖAW, Vienna, Austria.
43. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U. S. A. 95:588-593.
44. Rozen S, Skaletsky H. 2000. Primer3 on theWWWfor general users and for biologist programmers. Methods Mol. Biol. 132:365-386.
45. Ryu YJ, et al. 2006. Toll-like receptor 2 polymorphisms and nontuberculous mycobacterial lung diseases. Clin. Vaccine Immunol. 13:818-819.
46. Schroder NW, et al. 2005. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 175:2534-2540.
47. Schroder NW, et al. 2003. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J. Mol. Med. (Berlin) 81:368-372.
48. Schroder NW, et al. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Tolllike receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278: 15587-15594.
49. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
50. Smirnova I, et al. 2003. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl. Acad. Sci. U. S. A. 100:6075-6080.
51. Tabel Y, Berdeli A, Mir S. 2007. Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children. Int. J. Immunogenet. 34:399-405.
52. Takeda K, Takeuchi O, Akira S. 2002. Recognition of lipopeptides by Toll-like receptors. J. Endotoxin Res. 8:459-463.
53. Takeuchi O, et al. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.
54. Takeuchi O, et al. 2001. Discrimination of bacterial lipoproteins by Tolllike receptor 6. Int. Immunol. 13:933-940.
55. Team RDC. 2010. R: a language and environment for statistical computing. Team RDC, Vienna, Austria.
56. Texereau J, et al. 2005. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin. Infect. Dis. 41(Suppl. 7):S408-S415.
57. Tsui FW, et al. 2008. Toll-like receptor 2 variants are associated with acute reactive arthritis. Arthritis Rheum. 58:3436-3438.
58. van der Graaf CA, et al. 2003. Candida-specific interferon-gamma deficiency and Toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis. Neth. J. Med. 61:365-369.
59. Woehrle T, et al. 2008. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine 41:322-329.
60. Xue Y, et al. 2010. Toll-like receptors 2 and 4 gene polymorphisms in a southeastern Chinese population with tuberculosis. Int. J. Immunogenet. 37:135-138.
61. Yim JJ, et al. 2006. The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun. 7:150-155.
62. Yoon HJ, et al. 2006. Lack of Toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia. J. Korean Med. Sci. 21:979-982.
63. Zafra G, et al. 2008. Polymorphisms of Toll-like receptor 2 and 4 genes in Chagas disease. Mem. Inst. Oswaldo Cruz 103:27-30.